Read next
Clinical Trials Accelerate Deployment of Continuous Biomarker Monitoring Devices
Healthcare providers are expanding trial protocols for non-invasive continuous monitors to track metabolic metrics beyond standard blood glucose…
Insurers Restrict Coverage Criteria for GLP-1 Metabolic Therapies
Rising demand for weight-loss medications prompts healthcare payers to implement strict pre-authorization rules.
Targeted mRNA Vaccines Move into Phase 3 Clinical Trials for Oncology
Pharmaceutical developers deploy customized messenger RNA platforms to target patient-specific tumor mutations.
Digital Biomarkers Gain Regulatory Traction for Clinical Trials
Continuous monitoring data from wearable devices is gaining formal acceptance as secondary endpoints in clinical drug studies.
Clinical Adoption of Predictive Analytics Accelerates in Acute Care Facilities
Health systems are deploying real-time predictive models to optimize intensive care capacity and reduce patient readmission metrics.
Active Pharmaceutical Ingredient Scarcity Limits GLP-1 Production Expansion
Pharmaceutical manufacturers face sterile fill-finish capacity limits as global demand for metabolic therapies outpaces specialized production facilities.